Cannalean Biotechs

CBD-based Solutions for Treating Dyslipidemia

Active Pre-Funding Startup Bnei Brak Founded 2018-03

CannaLean Biotechs is committed to the research and development of a proprietary formulation of cannabidiol (CBD) and chitosan that can potentially benefit millions of patients with dyslipidemia. CannaLean uses a synthetic form of CBD, a non-psychotropic component of cannabis, with chitosan, a biocompatible, non-toxic, and non-immunogenic compound that enha…

SectorHealth Tech & Life Sciences
StagePre-Funding
Employees3
Founded2018-03
HQBnei Brak
Patents1
Confidence89
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical Cannabis
Technology
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients